drugset / Trial / NCT04972123
The Effect of CPC on Aborting Tilt Induced Syncope in Patients With a History of Vasovagal Syncope or Near Syncope
RandomizedParallel-groupTriple-blindTreatment
Summary
Syncope is defined as transient loss of consciousness associated with inability to maintain postural tone with rapid and spontaneous recovery. The purpose of this study is to assess the effects of sublingual administration of a new medication called CPC on tilt-induced syncope in patients with a history of vasovagal syncope (VVS) or near syncope. 140 participants will be randomized at the University of Wisconsin - Madison. Each participant will be in the study for 1 day.
Timeline
- Start
- 2021-07-20
- Primary completion
- 2023-08-25
- Completion
- 2023-08-31
Outcome
Missed primary endpoint
registry analysis (superiority test); CPC Adminstration vs Placebo Administration; p = 0.521 NCT04972123 ↗
registry analysis (superiority test); CPC Administration vs Placebo Administration; p = 0.574 NCT04972123 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Caffeine | Small molecule | — | Subcutaneous |
| Subject | Capsaicin | Small molecule | — | Subcutaneous |
| Subject | Phenylephrine | Small molecule | — | Subcutaneous |